AYUSH task force on COVID-19 looks at promising ayurvedic medicines for clinical drug trials

While the Drug Controller General of India has approved the protocol of using HCQ in COVID-19 treatment due to its immunomodulatory and antiviral effects, for restricted use under emergency situations, data to support the use of HCQ and CQ for COVID-19 seem to be limited and inconclusive, researchers have said in Current Science

from Sports News, Latest Sports News Headlines, Cricket News Today, World Cup 2019, Football News, Tennis News, Live Scores | The Indian Express
Read The Rest:indianexpress....